Condition: Asthma Bronchiale · Lung Function Tests · Bronchial Hyperresponsiveness · Sponsor: Helsinki University Central Hospital
The study includes a pre-study telephone interview with healthy controls to assess their eligibility for participation. During the study visit, a background information form and an asthma questionnaire are completed. At the study visit, a methacholine challenge test measuring airway hyperresponsiveness and an exhaled nitric oxide measurement are performed. The effect of medication intensification in asthma patients is further assessed through a telephone interview 1-2 months after the medication adjustment.
This description comes directly from the study's public registry record.
Janne Burman, PhD, MD · +358406517912 · janne.burman@hus.fi
Anssi Koivuselkä, Nurse · anssi.koivuselka@hus.fi
Always discuss trial participation with your own doctor first.
| HUS Skin and Allergy Hospital | Helsinki, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07031102